Effect of Paxlovid Treatment During Acute COVID-19 on Long COVID Onset: An EHR-Based Target Trial Emulation from the N3C and RECOVER Consortia

Alexander Preiss, Abhishek Bhatia, Leyna V. Aragon, John M. Baratta, Monika Baskaran, Frank Blancero, M. Daniel Brannock, Robert F. Chew, Iván Díaz, Megan Fitzgerald, Elizabeth P. Kelly, Andrea Zhou, Thomas W. Carton, Christopher G. Chute, Melissa Haendel, Richard Moffitt, Emily Pfaff N3C Consortium and the RECOVER EHR Cohort
doi: https://doi.org/10.1101/2024.01.20.24301525

Data Availability

Enclave and data access instructions can be found at https://covid.cd2h.org/for-researchers. All code used to produce the analyses in this manuscript is available within the N3C Data Enclave to users with valid login credentials to support reproducibility.

https://covid.cd2h.org/for-researchers

Back to top
Posted July 31, 2024.
Download PDF
Data/Code
Email
Effect of Paxlovid Treatment During Acute COVID-19 on Long COVID Onset: An EHR-Based Target Trial Emulation from the N3C and RECOVER Consortia
Alexander Preiss, Abhishek Bhatia, Leyna V. Aragon, John M. Baratta, Monika Baskaran, Frank Blancero, M. Daniel Brannock, Robert F. Chew, Iván Díaz, Megan Fitzgerald, Elizabeth P. Kelly, Andrea Zhou, Thomas W. Carton, Christopher G. Chute, Melissa Haendel, Richard Moffitt, Emily Pfaff
medRxiv 2024.01.20.24301525; doi: https://doi.org/10.1101/2024.01.20.24301525
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area